Form D · Pharmaceuticals

K-PAX Pharmaceuticals, Inc.

Mill Valley, CA · CIK 0001515314

Offering snapshot reported Oct 14, 2014 · SEC filing

Reported sold
$1.46M
Offering amount: $1.46M
Investors reported
1
Form D · investor count
Minimum accepted
$300K
Reported outside-investor minimum
First sale
Jan 31, 2013
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$730K$1.46MFeb 14, 2013: $1,160,000.00Feb 14, 2013Oct 14, 2014: $1,460,000.00Oct 14, 2014

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,160,000 → $1,460,000
  • Minimum accepted$1,160,000 → $300,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 14, 2014Amendment$1,460,000$300,000vs Feb 14, 20131SEC filing
Feb 14, 2013Initial$1,160,000No comparison1SEC filing
Mar 16, 2011Initial$300,000No comparison4SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-191859

Source: Form D, filed Oct 14, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jeffrey Cohen Director
Jon David Kaiser Director, Executive
Anne Marie Lahaderne Director, Executive
Larry Nathanson Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
655 Redwood Highway Suite #346
Mill Valley, CA, 94941